Global ParkinsonÕs Disease Treatment Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global ParkinsonÕs Disease Treatment Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC9261973
  • Published Date :
    May 31, 2024
  • Number of Pages :
    350

Product Description

The ParkinsonÕs Disease Treatment market was valued at US$ xx in 2023. The market for ParkinsonÕs Disease Treatment is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of ParkinsonÕs Disease Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading ParkinsonÕs Disease Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global ParkinsonÕs Disease Treatment market are discussed.

The market is segmented by types: 
    Oral
    Transdermal
    Subcutaneous
    Intestinal Infusion

It can be also divided by applications:
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

And this report covers the historical situation, present status and the future prospects of the global ParkinsonÕs Disease Treatment market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    Teva
    Roche
    Prothena
    Acorda Therapeutics
    Voyager Therapeutics
    Impax Pharmaceuticals
    UCB
    AbbVie
    MSD
    Orion Pharmaceuticals
    Intec Pharma
    NeuroDerm
    Adamas Therapeutics
    Acadia
    Sunovion
    GSK

Report Includes:
- xx data tables and xx additional tables
- An overview of global ParkinsonÕs Disease Treatment market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the ParkinsonÕs Disease Treatment market
- Profiles of major players in the industry, including     Teva,     Roche,     Prothena,     Acorda Therapeutics,     Voyager Therapeutics.....

Research objectives
    To study and analyze the global ParkinsonÕs Disease Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031.
    To understand the structure of ParkinsonÕs Disease Treatment market by identifying its various subsegments.
    Focuses on the key global ParkinsonÕs Disease Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the ParkinsonÕs Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of ParkinsonÕs Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global ParkinsonÕs Disease Treatment Market Report 2024, Forecast to 2031

1 Scope of the Study
    1.1 ParkinsonÕs Disease Treatment Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 ParkinsonÕs Disease Treatment Industry Overview
    2.1 Global ParkinsonÕs Disease Treatment Market Size (Million USD) Comparison by Regions (2024-2031)
        2.1.1 ParkinsonÕs Disease Treatment Global Import Market Analysis
        2.1.2 ParkinsonÕs Disease Treatment Global Export Market Analysis
        2.1.3 ParkinsonÕs Disease Treatment Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Oral
        2.2.2 Transdermal
        2.2.3 Subcutaneous
        2.2.4 Intestinal Infusion
    2.3 Market Analysis by Application
        2.3.1 Hospital Pharmacy
        2.3.2 Retail Pharmacy
        2.3.3 Online Pharmacy
    2.4 Global ParkinsonÕs Disease Treatment Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global ParkinsonÕs Disease Treatment Sales and Market Share by Manufacturer (2019-2023)
        2.4.2 Global ParkinsonÕs Disease Treatment Revenue and Market Share by Manufacturer (2019-2023)
        2.4.3 Global ParkinsonÕs Disease Treatment Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 ParkinsonÕs Disease Treatment Manufacturer Market Share
        2.4.5 Top 10 ParkinsonÕs Disease Treatment Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into ParkinsonÕs Disease Treatment Market
        2.4.7 Key Manufacturers ParkinsonÕs Disease Treatment Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 ParkinsonÕs Disease Treatment Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): ParkinsonÕs Disease Treatment Industry Impact
        2.7.1 How the Covid-19 is Affecting the ParkinsonÕs Disease Treatment Industry
        2.7.2 ParkinsonÕs Disease Treatment Business Impact Assessment - Covid-19
        2.7.3 Market Trends and ParkinsonÕs Disease Treatment Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 ParkinsonÕs Disease Treatment Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global ParkinsonÕs Disease Treatment Market Size Categorized by Regions
    4.1 Global ParkinsonÕs Disease Treatment Revenue, Sales and Market Share by Regions
        4.1.1 Global ParkinsonÕs Disease Treatment Sales and Market Share by Regions (2019-2023)
        4.1.2 Global ParkinsonÕs Disease Treatment Revenue and Market Share by Regions (2019-2023)
    4.2 Europe ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    4.3 APAC ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    4.4 North America ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    4.5 South America ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    4.6 Middle East & Africa ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)

5 Europe ParkinsonÕs Disease Treatment Market Size Categorized by Countries
    5.1 Europe ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Countries
        5.1.1 Europe ParkinsonÕs Disease Treatment Sales by Countries (2019-2023)
        5.1.2 Europe ParkinsonÕs Disease Treatment Revenue by Countries (2019-2023)
        5.1.3 Germany ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        5.1.4 UK ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        5.1.5 France ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        5.1.6 Russia ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        5.1.7 Italy ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        5.1.8 Spain ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    5.2 Europe ParkinsonÕs Disease Treatment Revenue (Value) by Manufacturers (2019-2023)
    5.3 Europe ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Type (2019-2023)
        5.3.1 Europe ParkinsonÕs Disease Treatment Sales Market Share by Type (2019-2023)
        5.3.2 Europe ParkinsonÕs Disease Treatment Revenue and Revenue Share by Type (2019-2023)
    5.4 Europe ParkinsonÕs Disease Treatment Sales Market Share by Application (2019-2023)

6 Asia-Pacific ParkinsonÕs Disease Treatment Market Size Categorized by Countries
    6.1 Asia-Pacific ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific ParkinsonÕs Disease Treatment Sales by Countries (2019-2023)
        6.1.2 Asia-Pacific ParkinsonÕs Disease Treatment Revenue by Countries (2019-2023)
        6.1.3 China ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        6.1.4 Japan ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        6.1.5 Korea ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        6.1.6 India ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        6.1.7 Southeast Asia ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        6.1.8 Australia ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    6.2 Asia-Pacific ParkinsonÕs Disease Treatment Sales and Revenue (Value) by Manufacturers (2019-2023)
    6.3 Asia-Pacific ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Type (2019-2023)
        6.3.1 Asia-Pacific ParkinsonÕs Disease Treatment Sales Market Share by Type (2019-2023)
        6.3.2 Asia-Pacific ParkinsonÕs Disease Treatment Revenue and Revenue Share by Type (2019-2023)
    6.4 Asia-Pacific ParkinsonÕs Disease Treatment Sales and Market Share by Application (2019-2023)

7 North America ParkinsonÕs Disease Treatment Market Size Categorized by Countries
    7.1 North America ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Countries
        7.1.1 North America ParkinsonÕs Disease Treatment Sales by Countries (2019-2023)
        7.1.2 North America ParkinsonÕs Disease Treatment Revenue by Countries (2019-2023)
        7.1.3 United States ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        7.1.4 Canada ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        7.1.5 Mexico ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    7.2 North America ParkinsonÕs Disease Treatment Revenue (Value) by Manufacturers (2019-2023)
    7.3 North America ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Type (2019-2023)
        7.3.1 North America ParkinsonÕs Disease Treatment Sales Market Share by Type (2019-2023)
        7.3.2 North America ParkinsonÕs Disease Treatment Revenue and Revenue Share by Type (2019-2023)
    7.4 North America ParkinsonÕs Disease Treatment Sales Market Share by Application (2019-2023)

8 South America ParkinsonÕs Disease Treatment Market Size Categorized by Countries
    8.1 South America ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Countries
        8.1.1 South America ParkinsonÕs Disease Treatment Sales by Countries (2019-2023)
        8.1.2 South America ParkinsonÕs Disease Treatment Revenue by Countries (2019-2023)
        8.1.3 Brazil ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    8.2 South America ParkinsonÕs Disease Treatment Revenue (Value) by Manufacturers (2019-2023)
    8.3 South America ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Type (2019-2023)
        8.3.1 South America ParkinsonÕs Disease Treatment Sales Market Share by Type (2019-2023)
        8.3.2 South America ParkinsonÕs Disease Treatment Revenue and Revenue Share by Type (2019-2023)
    8.4 South America ParkinsonÕs Disease Treatment Sales Market Share by Application (2019-2023)

9 Middle East and Africa ParkinsonÕs Disease Treatment Market Size Categorized by Countries
    9.1 Middle East and Africa ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa ParkinsonÕs Disease Treatment Sales by Countries (2019-2023)
        9.1.2 Middle East and Africa ParkinsonÕs Disease Treatment Revenue by Countries (2019-2023)
        9.1.3 GCC Countries ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        9.1.4 Turkey ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        9.1.5 Egypt ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
        9.1.6 South Africa ParkinsonÕs Disease Treatment Sales and Growth Rate (2019-2023)
    9.2 Middle East and Africa ParkinsonÕs Disease Treatment Revenue (Value) by Manufacturers (2019-2023)
    9.3 Middle East and Africa ParkinsonÕs Disease Treatment Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa ParkinsonÕs Disease Treatment Sales Market Share by Type (2019-2023)
        9.3.2 Middle East and Africa ParkinsonÕs Disease Treatment Revenue and Revenue Share by Type (2019-2023)
    9.4 Middle East and Africa ParkinsonÕs Disease Treatment Sales Market Share by Application (2019-2023)

10 Global ParkinsonÕs Disease Treatment Market Segment by Type
    10.1 Global ParkinsonÕs Disease Treatment Revenue, Sales and Market Share by Type (2019-2023)
        10.1.1 Global ParkinsonÕs Disease Treatment Sales and Market Share by Type (2019-2023)
        10.1.2 Global ParkinsonÕs Disease Treatment Revenue and Market Share by Type (2019-2023)
    10.2 Oral Sales Growth Rate and Price
        10.2.1 Global Oral Sales Growth Rate (2019-2023)
        10.2.2 Global Oral Price (2019-2023)
    10.3 Transdermal Sales Growth Rate and Price
        10.3.1 Global Transdermal Sales Growth Rate (2019-2023)
        10.3.2 Global Transdermal Price (2019-2023)
    10.4 Subcutaneous Sales Growth Rate and Price
        10.4.1 Global Subcutaneous Sales Growth Rate (2019-2023)
        10.4.2 Global Subcutaneous Price (2019-2023)
    10.5 Intestinal Infusion Sales Growth Rate and Price
        10.5.1 Global Intestinal Infusion Sales Growth Rate (2019-2023)
        10.5.2 Global Intestinal Infusion Price (2019-2023)

11 Global ParkinsonÕs Disease Treatment Market Segment by Application
    11.1 Global ParkinsonÕs Disease TreatmentSales Market Share by Application (2019-2023)
    11.2 Hospital Pharmacy Sales Growth Rate (2019-2023)
    11.3 Retail Pharmacy Sales Growth Rate (2019-2023)
    11.4 Online Pharmacy Sales Growth Rate (2019-2023)

12 Market Forecast for ParkinsonÕs Disease Treatment
    12.1 Global ParkinsonÕs Disease Treatment Revenue, Sales and Growth Rate (2024-2031)
    12.2 ParkinsonÕs Disease Treatment Market Forecast by Regions (2024-2031)
        12.2.1 Europe ParkinsonÕs Disease Treatment Market Forecast (2024-2031)
        12.2.2 APAC ParkinsonÕs Disease Treatment Market Forecast (2024-2031)
        12.2.3 North America ParkinsonÕs Disease Treatment Market Forecast (2024-2031)
        12.2.4 South America ParkinsonÕs Disease Treatment Market Forecast (2024-2031)
        12.2.5 Middle East & Africa ParkinsonÕs Disease Treatment Market Forecast (2024-2031)
    12.3 ParkinsonÕs Disease Treatment Market Forecast by Type (2024-2031)
        12.3.1 Global ParkinsonÕs Disease Treatment Sales Forecast by Type (2024-2031)
        12.3.2 Global ParkinsonÕs Disease Treatment Market Share Forecast by Type (2024-2031)
    12.4 ParkinsonÕs Disease Treatment Market Forecast by Application (2024-2031)
        12.4.1 Global ParkinsonÕs Disease Treatment Sales Forecast by Application (2024-2031)
        12.4.2 Global ParkinsonÕs Disease Treatment Market Share Forecast by Application (2024-2031)

13 Analysis of ParkinsonÕs Disease Treatment Industry Key Manufacturers
    13.1 Teva
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 Teva ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.1.4 Main Business Overview
        13.1.5 Teva News
    13.2 Roche
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 Roche ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.2.4 Main Business Overview
        13.2.5 Roche News
    13.3 Prothena
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 Prothena ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.3.4 Main Business Overview
        13.3.5 Prothena News
    13.4 Acorda Therapeutics
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Acorda Therapeutics ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.4.4 Main Business Overview
        13.4.5 Acorda Therapeutics News
    13.5 Voyager Therapeutics
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Voyager Therapeutics ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.5.4 Main Business Overview
        13.5.5 Voyager Therapeutics News
    13.6 Impax Pharmaceuticals
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Impax Pharmaceuticals ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.6.4 Main Business Overview
        13.6.5 Impax Pharmaceuticals News
    13.7 UCB
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 UCB ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.7.4 Main Business Overview
        13.7.5 UCB News
    13.8 AbbVie
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 AbbVie ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.8.4 Main Business Overview
        13.8.5 AbbVie News
    13.9 MSD
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 MSD ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.9.4 Main Business Overview
        13.9.5 MSD News
    13.10 Orion Pharmaceuticals
        13.10.1 Company Details
        13.10.2 Product Information
        13.10.3 Orion Pharmaceuticals ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.10.4 Main Business Overview
        13.10.5 Orion Pharmaceuticals News
    13.11 Intec Pharma
        13.11.1 Company Details
        13.11.2 Product Information
        13.11.3 Intec Pharma ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.11.4 Main Business Overview
        13.11.5 Intec Pharma News
    13.12 NeuroDerm
        13.12.1 Company Details
        13.12.2 Product Information
        13.12.3 NeuroDerm ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.12.4 Main Business Overview
        13.12.5 NeuroDerm News
    13.13 Adamas Therapeutics
        13.13.1 Company Details
        13.13.2 Product Information
        13.13.3 Adamas Therapeutics ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.13.4 Main Business Overview
        13.13.5 Adamas Therapeutics News
    13.14 Acadia
        13.14.1 Company Details
        13.14.2 Product Information
        13.14.3 Acadia ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.14.4 Main Business Overview
        13.14.5 Acadia News
    13.15 Sunovion
        13.15.1 Company Details
        13.15.2 Product Information
        13.15.3 Sunovion ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.15.4 Main Business Overview
        13.15.5 Sunovion News
    13.16 GSK
        13.16.1 Company Details
        13.16.2 Product Information
        13.16.3 GSK ParkinsonÕs Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.16.4 Main Business Overview
        13.16.5 GSK News

14 Research Findings and Conclusion

15 Appendix

Search results for Technology and Media Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Biotechnology

Top Rated Products